Clinical Trials Logo

Arthritis Shoulder clinical trials

View clinical trials related to Arthritis Shoulder.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06080412 Recruiting - Orthopedic Disorder Clinical Trials

Blueprint® Mixed Reality Pilot Study

BLUEMR
Start date: February 8, 2024
Phase:
Study type: Observational

A pilot Single-Arm, Multicenter, Prospective, Post-Market 6 months Follow-Up Clinical Investigation to Evaluate the Safety and Effectiveness of the Blueprint Mixed Reality HOLOBLUEPRINTâ„¢ (HOLOBLUEPRINTâ„¢).

NCT ID: NCT05297305 Recruiting - Clinical trials for Rotator Cuff Injuries

Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty

Start date: October 20, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to compare the effect of different ways to place the component that goes at the top of the humerus (upper arm) in reverse total shoulder replacement. Some surgeons place the humeral tray component sitting on the bone while others place it in the bone. Changing the way that the humeral component is placed may change how much the arm can raise up or turn out/in after surgery for some patients. This study compares patients with inlay humeral component (tray sits in the upper arm bone) versus onlay humeral component (tray sits on top of the upper arm bone) to see if there are differences in range of motion or function after surgery.

NCT ID: NCT05062252 Recruiting - Arthritis Shoulder Clinical Trials

Mirror Medacta Shoulder System Pivotal Trial

Start date: January 5, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate safety and efficacy of the Mirror Medacta Shoulder System in total shoulder arthroplasty.

NCT ID: NCT04949087 Recruiting - Arthritis Shoulder Clinical Trials

Efficacy of Intra-articular Injections for the Treatment of Primary Glenohumeral Osteoarthritis(GHOA)

GHOA
Start date: March 13, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the efficacy of intra-articular corticosteroid injections versus platelet-rich plasma injections for non-operative treatment of primary glenohumeral osteoarthritis. The efficacy of intra-articular injections, outside of hyaluronic acid, for the treatment of glenohumeral OA is not known, yet these treatments are commonly used with hopes of providing patients with symptomatic relief that can hopefully delay or prevent the need for shoulder arthroplasty. This study will help elucidate the therapeutic benefit of corticosteroid and Platelet Rich Plasma (PRP) injections in this patient population.

NCT ID: NCT04728282 Recruiting - Arthritis Shoulder Clinical Trials

Comparison of Lateralized RTSA With and Without Subscapularis Repair

Start date: November 1, 2021
Phase: Early Phase 1
Study type: Interventional

The purpose of this double-blind randomized controlled trial is to compare patient-reported, clinical, and functional outcomes in patients undergoing RTSA with and without subscapularis repair after placement of a modern "lateralized" implant over the course of 24-months postoperative.

NCT ID: NCT04629391 Recruiting - Arthritis Shoulder Clinical Trials

Anatomic TSA vs RTSA for Glenohumeral Arthritis

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

There are no published prospective studies that compared 2-year functional outcomes of RTSA and anatomic TSA for the treatment of primary glenohumeral osteoarthritis with intact rotator cuffs and no excessive glenoid retroversion. The primary goal of our prospective randomized study is to determine whether RTSA have at least as good results as anatomic TSA (non-inferiority), in patients with glenohumeral osteoarthritis, without rotator cuff tears nor significant glenoid retroversion.